Sentences with phrase «pancreatic cancer research center»

The first thing you notice about Diane Simeone, M.D., the Lazar J. Greenfield Professor of Surgery and director of the Pancreatic Cancer Research Center, is her tireless passion for finding better ways to detect and treat pancreatic cancer.

Penn Medicine's Pancreatic Cancer Research Center is a leading edge, translational research program that combines basic science research and clinical investigation.

Read more about the Pancreatic Cancer Research Center including clinical trials that are available for all stages of pancreatic cancer.

Editor's note: This is part of a series of blogs that focus on members of the Pancreatic Cancer Research Center.

We are keenly dependent on biostatisticians for ensuring that our clinical trials yield useful information for future generations of patients,» says Maitra, who is the scientific director for the Sheikh Ahmed Pancreatic Cancer Research Center.

Not exact matches

Helmy Eltoukhy, Co-founder and CEO, Guardant Health Dr. Sam Hanash, Director, Red and Charline McCombs Institute for the Early Detection and Treatment of Cancer, MD Anderson Cancer Center Dr. Anirban Maitra, Scientific Director, Sheikh Ahmed Center for Pancreatic Cancer Research, MD Anderson Cancer Center Moderator: Clifton Leaf, Fortune

«This research represents a big step forward in understanding why some tumors are more aggressive than others and being able to predict rationally which neoantigens will be the most effective at stimulating an immune response,» said Dr. Balachandran, a member of the David M. Rubenstein Center for Pancreatic Cancer Research at MSK, and corresponding author of the companion study inresearch represents a big step forward in understanding why some tumors are more aggressive than others and being able to predict rationally which neoantigens will be the most effective at stimulating an immune response,» said Dr. Balachandran, a member of the David M. Rubenstein Center for Pancreatic Cancer Research at MSK, and corresponding author of the companion study inResearch at MSK, and corresponding author of the companion study in Nature.

A clinical trial conducted by researchers at the Virginia G. Piper Cancer Center Clinical Trials, a partnership between Scottsdale Healthcare and the Translational Genomics Research Institute (TGen), showed that a new drug called MM - 398, given in combination with 5 - flourouracil (5FU) and leucovorin, produced a significant overall survival rate in patients with advanced, previously - treated pancreatic cCancer Center Clinical Trials, a partnership between Scottsdale Healthcare and the Translational Genomics Research Institute (TGen), showed that a new drug called MM - 398, given in combination with 5 - flourouracil (5FU) and leucovorin, produced a significant overall survival rate in patients with advanced, previously - treated pancreatic cancercancer.

Adding two blood - borne proteins associated with cancer cell migration increases the predictive ability of the current biomarker for pancreatic cancer to detect early stage disease, a research team from The University of Texas MD Anderson Cancer Center reports in the Journal of the National Cancer Instcancer cell migration increases the predictive ability of the current biomarker for pancreatic cancer to detect early stage disease, a research team from The University of Texas MD Anderson Cancer Center reports in the Journal of the National Cancer Instcancer to detect early stage disease, a research team from The University of Texas MD Anderson Cancer Center reports in the Journal of the National Cancer InstCancer Center reports in the Journal of the National Cancer InstCancer Institute.

The research team includes investigators from Mayo Clinic in Florida and Mayo Clinic SPORE in Pancreatic Cancer, one of three cancer centers in the U.S. to receive a Specialized Program of Research Excellence (SPORE) grant for pancreatic cancer from the National Cancer Inresearch team includes investigators from Mayo Clinic in Florida and Mayo Clinic SPORE in Pancreatic Cancer, one of three cancer centers in the U.S. to receive a Specialized Program of Research Excellence (SPORE) grant for pancreatic cancer from the National Cancer Pancreatic Cancer, one of three cancer centers in the U.S. to receive a Specialized Program of Research Excellence (SPORE) grant for pancreatic cancer from the National Cancer InstCancer, one of three cancer centers in the U.S. to receive a Specialized Program of Research Excellence (SPORE) grant for pancreatic cancer from the National Cancer Instcancer centers in the U.S. to receive a Specialized Program of Research Excellence (SPORE) grant for pancreatic cancer from the National Cancer InResearch Excellence (SPORE) grant for pancreatic cancer from the National Cancer pancreatic cancer from the National Cancer Instcancer from the National Cancer InstCancer Institute.

According to a new «proof of principle» study published in Aug. 27 issue of Cancer Prevention Research, Moffitt Cancer Center researchers hope to improve pancreatic cancer survival rates by identifying markers in the blood that can pinpoint patients with premalignant pancreatic lesions called intraductal papillary mucinous neoplasms (ICancer Prevention Research, Moffitt Cancer Center researchers hope to improve pancreatic cancer survival rates by identifying markers in the blood that can pinpoint patients with premalignant pancreatic lesions called intraductal papillary mucinous neoplasms (ICancer Center researchers hope to improve pancreatic cancer survival rates by identifying markers in the blood that can pinpoint patients with premalignant pancreatic lesions called intraductal papillary mucinous neoplasms (Icancer survival rates by identifying markers in the blood that can pinpoint patients with premalignant pancreatic lesions called intraductal papillary mucinous neoplasms (IPMNs).

This new partnership, called the Florida Pancreas Collaborative, represents the first state - wide multi-cancer center collaboration dedicated to conducting research on IPMNs with the ultimate goal of promoting the prevention and early detection of pancreatic cancer.

This research was supported by grants from the National Institutes of Health (CA038548, CA140599, CA179991, CA180682), and by the AACR Pancreatic Cancer Action Network, Vanderbilt GI SPORE and Vanderbilt - Ingram Cancer Center.

Health and Medicine Reporter Research AACR Pancreatic Cancer Action Network featured - Reporter gi spore Nature Genetics NCI NIH Oliver McDonald pancreatic cancer pathology microbiology and immunology Reporter Jan 20 2017 Vanderbilt Ingram CanPancreatic Cancer Action Network featured - Reporter gi spore Nature Genetics NCI NIH Oliver McDonald pancreatic cancer pathology microbiology and immunology Reporter Jan 20 2017 Vanderbilt Ingram Cancer Cancer Action Network featured - Reporter gi spore Nature Genetics NCI NIH Oliver McDonald pancreatic cancer pathology microbiology and immunology Reporter Jan 20 2017 Vanderbilt Ingram Canpancreatic cancer pathology microbiology and immunology Reporter Jan 20 2017 Vanderbilt Ingram Cancer cancer pathology microbiology and immunology Reporter Jan 20 2017 Vanderbilt Ingram Cancer Cancer Center

The team used pancreatic organoid technology developed in the lab of Professor David Tuveson, Director of CSHL's Cancer Center and Director of Research for the Lustgarten Foundation.

Brentnall collaborates with Center investigators Drs. Sunil Hingorani, Meg Mandelson and John Potter on other pancreatic - cancer research.

APRIL 23, 2015 — Two powerhouses of cancer support — the American Association for Cancer Research (AACR) and the Pancreatic Cancer Action Network (PanCAN)-- have jointly awarded Georgetown Lombardi Comprehensive Cancer Center and Thomas Jefferson University in Philadelphia $ 1 million over three years to determine whether molecularly tailored treatment for pancreatic cancer improves survival compared with the current standard ofcancer support — the American Association for Cancer Research (AACR) and the Pancreatic Cancer Action Network (PanCAN)-- have jointly awarded Georgetown Lombardi Comprehensive Cancer Center and Thomas Jefferson University in Philadelphia $ 1 million over three years to determine whether molecularly tailored treatment for pancreatic cancer improves survival compared with the current standard ofCancer Research (AACR) and the Pancreatic Cancer Action Network (PanCAN)-- have jointly awarded Georgetown Lombardi Comprehensive Cancer Center and Thomas Jefferson University in Philadelphia $ 1 million over three years to determine whether molecularly tailored treatment for pancreatic cancer improves survival compared with the current standarPancreatic Cancer Action Network (PanCAN)-- have jointly awarded Georgetown Lombardi Comprehensive Cancer Center and Thomas Jefferson University in Philadelphia $ 1 million over three years to determine whether molecularly tailored treatment for pancreatic cancer improves survival compared with the current standard ofCancer Action Network (PanCAN)-- have jointly awarded Georgetown Lombardi Comprehensive Cancer Center and Thomas Jefferson University in Philadelphia $ 1 million over three years to determine whether molecularly tailored treatment for pancreatic cancer improves survival compared with the current standard ofCancer Center and Thomas Jefferson University in Philadelphia $ 1 million over three years to determine whether molecularly tailored treatment for pancreatic cancer improves survival compared with the current standarpancreatic cancer improves survival compared with the current standard ofcancer improves survival compared with the current standard of care.

At Penn Medicine's Abramson Cancer Center, our patients with pancreatic cancer receive their care from a team of nationally recognized experts in the diagnosis, treatment and research of pancreatic cCancer Center, our patients with pancreatic cancer receive their care from a team of nationally recognized experts in the diagnosis, treatment and research of pancreatic ccancer receive their care from a team of nationally recognized experts in the diagnosis, treatment and research of pancreatic cancercancer.